Joe Dupere

Chief Executive Officer at Ixaka Ltd.

Health Technology

Profile

Joe Dupere is currently the Chief Executive Officer and Director at Ixaka Ltd.
since 2015.
Prior to this, he worked as a Business Development Officer at RIEMSER Pharma GmbH.

Joe Dupere active positions

Companies	Position	Start
Ixaka Ltd. Ixaka Ltd. BiotechnologyHealth Technology Ixaka Ltd. engages in the development of advanced cell-based therapeutics for the treatment of critical limb ischemia. The company was founded by Gaby Salem and Vicente Saez Gonzalez in 2015 and is headquartered in London, the United Kingdom.	Chief Executive Officer	2015-01-31

All active positions of Joe Dupere

Former positions of Joe Dupere

Companies	Position	End
RIEMSER Pharma GmbH RIEMSER Pharma GmbH Pharmaceuticals: MajorHealth Technology RIEMSER Pharma GmbH develops, manufactures and distributes pharmaceutical products. It operates as an international specialty pharmaceutical company and core competencies cover the areas oncology, particularly supportive therapies, anti-infectives and dermatology. The company was founded in 1992 and is headquartered in Greifswald, Germany.	Corporate Officer/Principal	-

See the detail of Joe Dupere's experience

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Joe Dupere's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	2
RIEMSER Pharma GmbH RIEMSER Pharma GmbH Pharmaceuticals: MajorHealth Technology RIEMSER Pharma GmbH develops, manufactures and distributes pharmaceutical products. It operates as an international specialty pharmaceutical company and core competencies cover the areas oncology, particularly supportive therapies, anti-infectives and dermatology. The company was founded in 1992 and is headquartered in Greifswald, Germany.	Health Technology
Ixaka Ltd. Ixaka Ltd. BiotechnologyHealth Technology Ixaka Ltd. engages in the development of advanced cell-based therapeutics for the treatment of critical limb ischemia. The company was founded by Gaby Salem and Vicente Saez Gonzalez in 2015 and is headquartered in London, the United Kingdom.	Health Technology